Menu

Latest News

Here you can find all the latest news from the UCL Innovative Clinical Trials Unit (formerly the MRC CTU at UCL). 

BREATHER+ results published in The Lancet HIV confirm that taking HIV medicines every day without breaks remains the best way to keep the virus under control.
Evidence from the PATCH and STAMPEDE trial networks broadens treatment options for people with prostate cancer who are starting long-term hormone therapy.
New findings from UCL and University of Cape Town show that PET-CT scans and AI-read X-Rays can detect evidence of TB in the lungs as much as 5 years before final diagnosis.
These results from the GASTROSAM trial could lead to a review of the existing treatment rehydration guidelines for children who are suffering severe acute malnutrition.
Results from the D3 (Penta 21) trial presented at CROI show that using dolutegravir and lamivudine is safe and as effective as using a combination of three HIV medicines, to keep the virus under control.